Lepu Biopharma Co., Ltd. (HKG:2157)

Hong Kong · Delayed Price · Currency is HKD

3.810

+0.110 (2.97%)

Jun 18, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Sales of Pharmaceutical Products and Research and Development of New Drugs	934.87M	367.79M	225.35M	15.57M	-
Sales of Pharmaceutical Products and Research and Development of New Drugs Growth	154.18%	63.21%	1347.16%	-	-
Total	934.87M	367.79M	225.35M	15.57M	-
Total Growth	154.18%	63.21%	1347.16%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
People's Republic of China (PRC)	571.08M	345.83M	101.39M	15.57M	-
People's Republic of China (PRC) Growth	65.13%	241.11%	551.07%	-	-
Overseas	363.79M	21.96M	123.97M	-	-
Overseas Growth	1556.30%	-82.28%	-	-	-
Total	934.87M	367.79M	225.35M	15.57M	-
Total Growth	154.18%	63.21%	1347.16%	-	-